After nearly 20 years, the Food and Drug Administration (FDA) has approved several new drugs to treat Alzheimer’s disease since 2021. These drugs, primarily antibody therapies, target toxic protein aggregates in the brain. Their approval has generated both excitement and controversy. The key question remains: Are these drugs truly effective? Alzheimer’s disease is a neurodegenerative …
Continue reading “FDA Approves New Alzheimer’s Drugs: Hope or Hype?”
